Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee.
Esteso P, Auerbach S, Bansal N, Harris R, Soslow J, Birnbaum B, Conway J, Cripe L, Nandi D, Hayes E, Gambetta K, Hall E, Hsu D, Kaufman B, Rosenthal D, Kirmani S, Ploutz M, Lal A, Peng D, Villa C, Shugh S, Wittlieb-Weber C, Shih R. Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee. Cardiology In The Young 2025, 35: 770-775. PMID: 40012319, DOI: 10.1017/s1047951125000587.Peer-Reviewed Original ResearchDuchenne muscular dystrophyCardiac medicationsMuscular dystrophyCardiac careAdvanced Cardiac Therapies Improving Outcomes NetworkManagement of Duchenne muscular dystrophyImprove cardiac outcomesLoss of dystrophinAmerican College of CardiologyOptimal therapeutic efficacyExpert opinion statementsAmerican Heart AssociationCardiac outcomesImprove cardiac prognosisCardiomyopathy progressionTherapeutic efficacyCardiac prognosisHeart AssociationDisease progressionCardiac treatmentConsensus recommendationsOutcomes NetworkAmerican CollegeDystrophyCardiomyopathy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply